Literature DB >> 19079221

Molecular analysis of the intestinal microflora in IBD.

G W Tannock1.   

Abstract

Nucleic acid-based (molecular) analytical methods have utility in discriminating between bowel microbiota of altered compositions. This has been demonstrated in studies involving both experimental animals and humans with inflammation of the bowel. Although alterations in the composition of the microbiota can be demonstrated, future studies need to provide functional links between the candidate proinflammatory agents and disease processes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19079221     DOI: 10.1038/mi.2008.54

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  19 in total

Review 1.  Relationship between intestinal microbiota and colorectal cancer.

Authors:  Gokhan Cipe; Ufuk Oguz Idiz; Deniz Firat; Huseyin Bektasoglu
Journal:  World J Gastrointest Oncol       Date:  2015-10-15

2.  Mucosal bacterial microflora and mucus layer thickness in adolescents with inflammatory bowel disease.

Authors:  Krzysztof Fyderek; Magdalena Strus; Kinga Kowalska-Duplaga; Tomasz Gosiewski; Andrzej Wedrychowicz; Urszula Jedynak-Wasowicz; Małgorzata Sładek; Stanisław Pieczarkowski; Paweł Adamski; Piotr Kochan; Piotr B Heczko
Journal:  World J Gastroenterol       Date:  2009-11-14       Impact factor: 5.742

Review 3.  Mucosal immunity in human and simian immunodeficiency lentivirus infections.

Authors:  J M Brenchley
Journal:  Mucosal Immunol       Date:  2013-04-03       Impact factor: 7.313

Review 4.  The struggle within: microbial influences on colorectal cancer.

Authors:  Janelle C Arthur; Christian Jobin
Journal:  Inflamm Bowel Dis       Date:  2011-01       Impact factor: 5.325

Review 5.  Microbial translocation across the GI tract.

Authors:  Jason M Brenchley; Daniel C Douek
Journal:  Annu Rev Immunol       Date:  2012-01-03       Impact factor: 28.527

Review 6.  Probiotics and the gut microbiota in intestinal health and disease.

Authors:  Mélanie G Gareau; Philip M Sherman; W Allan Walker
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-07-27       Impact factor: 46.802

Review 7.  Emerging drugs for the treatment of ulcerative colitis.

Authors:  Luca Pastorelli; Theresa T Pizarro; Fabio Cominelli; Maurizio Vecchi
Journal:  Expert Opin Emerg Drugs       Date:  2009-09       Impact factor: 4.191

8.  The bowel microbiota and inflammatory bowel diseases.

Authors:  Gerald W Tannock
Journal:  Int J Inflam       Date:  2010-08-05

9.  Impact of intestinal microbiota on intestinal luminal metabolome.

Authors:  Mitsuharu Matsumoto; Ryoko Kibe; Takushi Ooga; Yuji Aiba; Shin Kurihara; Emiko Sawaki; Yasuhiro Koga; Yoshimi Benno
Journal:  Sci Rep       Date:  2012-01-25       Impact factor: 4.379

10.  Development of gut inflammation in mice colonized with mucosa-associated bacteria from patients with ulcerative colitis.

Authors:  Zhengyu Du; Tomas Hudcovic; Jakub Mrazek; Hana Kozakova; Dagmar Srutkova; Martin Schwarzer; Helena Tlaskalova-Hogenova; Martin Kostovcik; Miloslav Kverka
Journal:  Gut Pathog       Date:  2015-12-21       Impact factor: 4.181

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.